We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Molecular Pathway Decreases Cell Adhesion and Initiates Metastasis

By LabMedica International staff writers
Posted on 28 Jul 2014
Print article
A recent paper outlined a molecular pathway that enables lung cancer cells to migrate away from the site of the primary tumor and become established in other parts of the body.

Investigators at the Salk Institute for Biological Studies (La Jolla, CA, USA) linked a virtual alphabet soup of genes and their protein products to the epithelial-to-mesenchymal transition (EMT) that is a prerequisite for metastasis.

The serine/threonine kinase LKB1 (liver kinase B1) is a tumor suppressor gene whose loss is associated with increased metastatic potential. In an effort to define biochemical signatures of metastasis associated with LKB1 loss, the investigators discovered that the EMT transcription factor Snail1 was uniquely upregulated upon LKB1 deficiency across cell types. Snail1 is a central regulator of epithelial cell adhesion and movement in EMTs during embryo development; a process reactivated during cancer metastasis. The ability of LKB1 to suppress Snail1 levels was independent of AMPK (AMP-activated protein kinase) but required the related kinases MARK1 (MAP/microtubule affinity-regulating kinase 1) and MARK4 (MAP/microtubule affinity-regulating kinase 4).

In a screen for substrates of the kinases involved in Snail regulation, the investigators identified the scaffolding protein DIXDC1 (DIX domain containing 1), a positive regulator of the Wnt signaling pathway that is associated with gamma tubulin at the centrosome. Similar to loss of LKB1, DIXDC1 depletion resulted in upregulation of Snail1 in a FAK (Focal Adhesion Kinase)-dependent manner, leading to increased cell invasion. FAK is a focal adhesion-associated protein kinase involved in cellular adhesion and spreading processes. It has been shown that when FAK was blocked, breast cancer cells became less metastatic due to decreased mobility.

MARK1 phosphorylation of DIXDC1 was required for its localization to focal adhesions and ability to suppress metastasis in mice. DIXDC1 is frequently downregulated in human cancers, which correlates with poor survival.

"Lung cancer, even when it is discovered early, is often able to metastasize almost immediately and take hold throughout the body," said senior author Dr. Reuben J. Shaw, professor of molecular and cell biology at the Salk Institute for Biological Studies. "The reason behind why some tumors do that and others do not has not been very well understood. Now, through this work, we are beginning to understand why some subsets of lung cancer are so invasive. The good news is that this finding predicts that patients missing either gene should be sensitive to new therapies targeting focal adhesion enzymes, which are currently being tested in early-stage clinical trials."

The study was published in the July 17, 2014, online edition of the journal Molecular Cell.

Related Links:

Salk Institute for Biological Studies


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.